This is to inform you that the Board of Directors of National Peroxide Limited (formerly known as NPL Chemicals Limited) ('the Company') at their meeting held today i.e., on November 03, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.7 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of National Peroxide Limited (BSE: 544205) approved the unaudited financial results for Q2 FY26 and H1 FY26 (ended September 30, 2025). Revenue from Operations in Q2 FY26 rose to about ₹7,702 lakhs versus ₹6,829 lakhs in Q2 FY25 (around 12.8% YoY growth). However, the company swung to a loss before tax of about ₹136 lakhs in Q2 FY26 compared to a profit of ₹63 lakhs in Q2 FY25, and Q2 EPS turned negative at ₹(3.91) versus ₹1.55 earlier. For the half-year, revenue declined roughly 10.6% YoY to ₹13,494 lakhs (versus ₹15,101 lakhs in H1 FY25), and PAT fell sharply. Statutory auditor Kalyaniwalla & Mistry LLP issued an unmodified (clean) limited review conclusion.
The quarter shows a sharp drop in profitability despite modest revenue growth, and the half-year revenue base has shrunk — a worrying combination for shareholders that may pressure the stock until margin recovery or volume pickup is visible.